Having trouble accessing articles? Reset your cache.

AGS-003: Additional Phase II data

Additional data from an ongoing, open-label Phase II trial in 22 newly diagnosed patients who have undergone nephrectomy showed that

Read the full 205 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE